HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback